Direkt zum Inhalt
Merck

Wichtige Dokumente

Gesamtdokumentation anzeigen

Fortfahren mit

EXTRA2

Mouse ExtrAvidin® Peroxidase Staining Kit antibody produced in goat

Synonym(e):

ExtrAvidin® Peroxidase Staining Kits

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
PackungsgrößeSKUVerfügbarkeitPreis
1 kit
Bitte wenden Sie sich an den Kundendienst, um die Verfügbarkeit zu erfragen.
€900.00

Über diesen Artikel

NACRES:
NA.32
UNSPSC Code:
12352203

€900.00

Bitte wenden Sie sich an den Kundendienst, um die Verfügbarkeit zu erfragen.
​
Großbestellung anfragen
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten

antibody product type

secondary antibodies

Quality Level

200

usage

sufficient for 2,000 tests ELISA, Immunoblotting, sufficient for 200 tests Immunohistology

shipped in

wet ice

storage temp.

2-8°C

target post-translational modification

unmodified

General description

Contain universal reagents for use with primary antibodies in immunohistology, ELISA, and immunoblotting.
ExtrAvidin® is a unique form of avidin, available only from Sigma, that combines the high specificity and affinity of avidin for biotin with low non-specific binding at physiological pH.
These kits comprise universal reagents for use with primary antibodies in immunohistology, ELISA, and immunoblotting.
ExtrAvidin® is a unique form of avidin, available only from Sigma, that combines the high specificity and affinity of avidin for biotin with low non-specific binding at physiological pH. ExtrAvidin® peroxidase exhibits high sensitivity with low background.

Application

Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.
Immunohistochemistry (1 paper)

Features and Benefits

  • Use in immunohistology, ELISA, and immunoblotting assays.
  • Affinity Isolated Antibodies have been adsorbed with human IgG and IgM to minimize cross-reactivity.
  • Biotinylated antibodies contain a spacer which improves accessibility for the ExtrAvidin® conjugates.

Other Notes

• 3 mL ExtrAvidin®-Peroxidase
• 3 mL Biotinylated Secondary Antibodies
• Complete Instructions and Assay Protocols

Legal Information

ExtrAvidin is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

For U.S. Customers: Contains mercury; Do not place in trash - dispose according to local, state, or federal laws.

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
A5278SAB3700434SAB3701122
Mouse ExtrAvidin® Peroxidase Staining Kit antibody produced in goat

Sigma-Aldrich

EXTRA2

Mouse ExtrAvidin® Peroxidase Staining Kit antibody produced in goat

Anti-Mouse IgG (whole molecule)–Peroxidase antibody produced in goat IgG fraction of antiserum, buffered aqueous solution

Sigma-Aldrich

A5278

Anti-Mouse IgG (whole molecule)–Peroxidase antibody produced in goat

Anti-Swine IgG (H+L)-Peroxidase antibody produced in goat affinity isolated antibody, lyophilized powder

Sigma-Aldrich

SAB3700434

Anti-Swine IgG (H+L)-Peroxidase antibody produced in goat

Anti-Mouse IgG (H+L), F(ab′)2 fragment, highly cross adsorbed-Peroxidase antibody produced in goat affinity isolated antibody, lyophilized powder

Sigma-Aldrich

SAB3701122

Anti-Mouse IgG (H+L), F(ab′)2 fragment, highly cross adsorbed-Peroxidase antibody produced in goat

shipped in

wet ice

shipped in

dry ice

shipped in

wet ice

shipped in

wet ice

storage temp.

2-8°C

storage temp.

−20°C

storage temp.

2-8°C

storage temp.

2-8°C

usage

sufficient for 2,000 tests ELISA, Immunoblotting, sufficient for 200 tests Immunohistology

usage

-

usage

-

usage

-

Quality Level

200

Quality Level

200

Quality Level

100

Quality Level

100

target post-translational modification

unmodified

target post-translational modification

unmodified

target post-translational modification

unmodified

target post-translational modification

unmodified

antibody product type

secondary antibodies

antibody product type

secondary antibodies

antibody product type

secondary antibodies

antibody product type

secondary antibodies

Still not finding the right product?

Probieren Sie unser Produkt-Auswahlhilfe, um Ihre Auswahl einzugrenzen

Lagerklasse

12 - Non Combustible Liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

pictograms

Health hazard
GHS08

signalword

Danger

hcodes

H334

Hazard Classifications

Resp. Sens. 1

Zulassungslistungen

Zulassungslistungen werden hauptsächlich für chemische Produkte erstellt. Für nicht-chemische Produkte können hier nur begrenzte Angaben gemacht werden. Kein Eintrag bedeutet, dass keine der Komponenten gelistet ist. Es liegt in der Verantwortung des Benutzers, die sichere und legale Verwendung des Produkts zu gewährleisten.

54-64-8

CAS No.

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number
0000533861
0000533861
0000377873
0000377873
0000245216

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Suche nach COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Verwandter Inhalt

Matheus L Medeiros et al.
Journal of inflammation research, 14, 6477-6489 (2021-12-10)
Methylglyoxal (MGO) is a highly reactive dicarbonyl species implicated in diabetic-associated diseases. Acute lung injury (ALI) symptoms and prognosis are worsened by diabetes and obesity. Here, we hypothesized that elevated MGO levels aggravate ALI, which can be prevented by metformin.
Akila L Oliveira et al.
Frontiers in physiology, 13, 860342-860342 (2022-04-15)
Methylglyoxal (MGO) is a highly reactive dicarbonyl compound implicated in diabetes-associated diseases. In vascular tissues, MGO induces the formation of advanced glycation end products (AGEs) that bounds its receptor RAGE, initiating the downstream tissue injury. Outside the cardiovascular system, MGO
Vladimirs Pilipenko et al.
Neuropharmacology, 144, 319-326 (2018-11-09)
Early manifestations of Alzheimer's disease (AD) include neuroinflammation, disrupted neurotransmission and cognitive deficits. Impairment of the GABAergic system is essentially involved in the pathogenesis of AD. Traditionally, agonists of GABAA receptors at doses above 1 mg/kg are known to possess memory

Global Trade Item Number

SKUGTIN
EXTRA2-1KT04061834402435

Questions

Reviews

No rating value

Active Filters